Original article
In vitro activity of ceftobiprole and dalbavancin against a collection of coagulase-negative staphylococci isolates from clinical samples with reduced susceptibility to daptomycin and/or resistant to linezolid or glycopeptides
Evaluación de la actividad in vitro de ceftobiprol y dalbavancina frente a estafilococos coagulasa negativos con sensibilidad disminuida a daptomicina y/o resistentes a linezolid o glucopéptidos aislados de muestras clínicas
Read
377
Timeswas read the article
97
Total PDF
280
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 December | 20 | 3 | 23 |
| 2024 November | 27 | 4 | 31 |
| 2024 October | 22 | 7 | 29 |
| 2024 September | 29 | 5 | 34 |
| 2024 August | 29 | 4 | 33 |
| 2024 July | 11 | 10 | 21 |
| 2024 June | 15 | 3 | 18 |
| 2024 May | 22 | 3 | 25 |
| 2024 April | 2 | 0 | 2 |
| 2024 February | 1 | 0 | 1 |
| 2024 January | 2 | 0 | 2 |
| 2023 December | 3 | 0 | 3 |
| 2023 November | 97 | 37 | 134 |
| 2023 March | 0 | 4 | 4 |
| 2023 January | 0 | 3 | 3 |
| 2022 August | 0 | 14 | 14 |
Show all
